The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-3-(4-hydroxy-3-methoxyphenyl)-1-(4-(4-methylbenzyl)piperazin-1-yl)prop-2-en-1-one ID: ALA4876437
PubChem CID: 164627247
Max Phase: Preclinical
Molecular Formula: C22H26N2O3
Molecular Weight: 366.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(/C=C/C(=O)N2CCN(Cc3ccc(C)cc3)CC2)ccc1O
Standard InChI: InChI=1S/C22H26N2O3/c1-17-3-5-19(6-4-17)16-23-11-13-24(14-12-23)22(26)10-8-18-7-9-20(25)21(15-18)27-2/h3-10,15,25H,11-14,16H2,1-2H3/b10-8+
Standard InChI Key: IQMBEXLYUZMZHT-CSKARUKUSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
4.2826 -20.5825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2815 -21.4020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9895 -21.8110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6992 -21.4015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6964 -20.5789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9878 -20.1736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5748 -20.1740 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5746 -19.3568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5735 -21.8100 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4025 -20.1676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1118 -20.5735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8179 -20.1623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5272 -20.5682 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5279 -21.3839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2331 -21.7898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9417 -21.3820 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9406 -20.5638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2309 -20.1535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8149 -19.3451 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6494 -21.7906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3571 -21.3820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0623 -21.7912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7695 -21.3833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7700 -20.5652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0573 -20.1568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3530 -20.5670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4772 -20.1557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
2 9 1 0
5 10 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 1 0
13 18 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
12 19 2 0
16 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
24 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 366.46Molecular Weight (Monoisotopic): 366.1943AlogP: 3.07#Rotatable Bonds: 5Polar Surface Area: 53.01Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.89CX Basic pKa: 7.04CX LogP: 3.40CX LogD: 3.24Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.83Np Likeness Score: -0.48
References 1. Singh YP, Shankar G, Jahan S, Singh G, Kumar N, Barik A, Upadhyay P, Singh L, Kamble K, Singh GK, Tiwari S, Garg P, Gupta S, Modi G.. (2021) Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease., 46 [PMID:34481338 ] [10.1016/j.bmc.2021.116385 ]